Cargando…

Influenza vaccination and interruption of methotrexate in adult patients in the COVID-19 era: an ongoing dilemma

Detalles Bibliográficos
Autores principales:	Mehta, Puja, Sanchez, Emilie, Moraitis, Elena, Longley, Nicky, Lendrem, Dennis W, Giles, Ian P, Chambers, Rachel C, Ciurtin, Coziana, Isaacs, John D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833938/ https://www.ncbi.nlm.nih.gov/pubmed/33521669 http://dx.doi.org/10.1016/S2665-9913(20)30392-1

Ejemplares similares

Improving COVID-19 vaccine immunogenicity by interrupting methotrexate treatment
por: Sparks, Jeffrey A, et al.
Publicado: (2022)

Variability in counselling for adrenal insufficiency in COVID-19 and beyond: a survey of rheumatology practice
por: Mehta, Puja, et al.
Publicado: (2021)

JAK inhibitors in COVID-19: the need for vigilance regarding increased inherent thrombotic risk
por: Mehta, Puja, et al.
Publicado: (2020)

Granulocyte-macrophage colony stimulating factor in COVID-19: friend or foe?
por: Mehta, Puja, et al.
Publicado: (2021)

Is fibromyalgia associated with a unique cytokine profile? A systematic review and meta-analysis
por: O’Mahony, Luke Furtado, et al.
Publicado: (2021)

Pulling at the heart: COVID-19, race/ethnicity and ongoing disparities
por: Chin-Hong, Peter, et al.
Publicado: (2020)

Salty ice and the dilemma of ocean exoplanet habitability
por: Journaux, Baptiste
Publicado: (2022)

Preliminary results of an ongoing multicentric prospective study on hypertensive emergencies and urgencies in Italy
por: Kotruchin, Praew
Publicado: (2023)

Suspending methotrexate for 2 weeks after COVID-19 vaccination
por: Coates, Laura C, et al.
Publicado: (2022)

COVID-19 highlights the model dilemma in biomedical research
por: Adhikary, Partho Protim, et al.
Publicado: (2021)

Impact of methotrexate on first-dose COVID-19 mRNA vaccination
por: Connolly, Caoilfhionn M, et al.
Publicado: (2021)

Baricitinib in COVID-19: a coming-of-age from artificial intelligence to reducing mortality
por: Mehta, Puja, et al.
Publicado: (2022)

The ongoing nosologic dilemma with the metabolic syndrome
por: Vaidya, Ashok D. B.
Publicado: (2010)

Recommendations from national regulatory agencies for ongoing cancer trials during the COVID-19 pandemic
por: de Paula, Bruno H R, et al.
Publicado: (2020)

Ongoing asthma management in children during the COVID-19 pandemic: to step down or not to step down?
por: Abrams, Elissa Michele, et al.
Publicado: (2021)

Health and economic implications of the ongoing coronavirus disease (COVID-19) pandemic on women and children in Africa
por: Yeboah, Helena, et al.
Publicado: (2023)

Trained innate immunity, COVID-19 therapeutic dilemma, and fake science
por: Belizário, José Ernesto
Publicado: (2020)

Many-qubit protection-operation dilemma from the perspective of many-body localization
por: Silveri, Matti, et al.
Publicado: (2022)

Exploring the Evidence for an Immunomodulatory Role of Vitamin D in Juvenile and Adult Rheumatic Disease
por: Zou, Jiaqi, et al.
Publicado: (2021)

Local distribution infrastructure and robust vaccine manufacturing facilities in LMICs should be prioritised to tackle ongoing and future pandemic risk
por: Reza, Hasan Mahmud, et al.
Publicado: (2023)

Land, lava, and disaster create a social dilemma after the 2018 eruption of Kīlauea volcano
por: Houghton, Bruce F., et al.
Publicado: (2021)

The impact of COVID-19 pandemic on hospital admissions for nine diseases in Iran: insight from an interrupted time series analysis
por: Ahmadi, Sina, et al.
Publicado: (2022)

The dilemma of partial nephrectomy and surgical upstaging
por: dos Reis, Rodolfo Borges, et al.
Publicado: (2022)

Targeting hyperinflammation in infection: can we harness the COVID-19 therapeutics momentum to end the dengue drugs drought?
por: McBride, Angela, et al.
Publicado: (2021)

Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease
por: Haberman, Rebecca H, et al.
Publicado: (2022)

Pathogen detection in the CRISPR–Cas era
por: Sashital, Dipali G.
Publicado: (2018)

Diagnosis of EVALI in the COVID-19 era
por: Kazachkov, Mikhail, et al.
Publicado: (2020)

Mass gathering events and reducing further global spread of COVID-19: a political and public health dilemma
por: McCloskey, Brian, et al.
Publicado: (2020)

Missing outcomes in randomized trials: addressing the dilemma
por: Altman, Douglas G
Publicado: (2009)

Refractory rheumatoid vasculitis—a therapeutic dilemma
por: Watts, Richard A, et al.
Publicado: (2016)

The “discordant doppelganger dilemma”: SGLT2i mimics therapeutic carbohydrate restriction - food choice first over pharma?
por: Murray, Scott W., et al.
Publicado: (2021)

Cost-effectiveness versus treatment effectiveness: A radiation oncologist's dilemma in low-income and middle-income countries (LMIC)
por: Iyer, Priya
Publicado: (2022)

Computational thinking in the era of big data biology
por: Schatz, Michael C
Publicado: (2012)

Natural human knockouts and the era of genotype to phenotype
por: Alkuraya, Fowzan S
Publicado: (2015)

Offline: Science and politics in the era of COVID-19
por: Horton, Richard
Publicado: (2020)

Participant stress in the COVID-19 era and beyond
por: Goldfarb, Elizabeth V.
Publicado: (2020)

Infectious diseases in China in the post-SARS era
por: Gibney, Katherine B, et al.
Publicado: (2017)

Managing supply chain resilience in the era of VUCA
por: Gao, Ying, et al.
Publicado: (2021)

Prioritisation of COVID-19 boosters in the omicron era
por: Irving, Stephanie A, et al.
Publicado: (2022)

It Is Time to Implement Primary Prevention in the Workplace to Ameliorate the Ongoing U.S. Opioid Epidemic
por: Le, Aurora B., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l7jd5cut8rt88bie151lqstqun